Eligible participants , stratified by MTHFR C@T genotypes ( CC , CT , and TT ) , were randomly assigned to receive double-blind daily treatment with a single-pill combination containing enalapril , @ mg , and folic acid , @ mg ( n = @,@ ) or a tablet containing enalapril , @ mg , alone ( n = @,@ ) .